Melatonin Loaded in Injectable Platelet-Rich Fibrin in the Management Periodontitis (NCT07316582) | Clinical Trial Compass
By InvitationPhase 4
Melatonin Loaded in Injectable Platelet-Rich Fibrin in the Management Periodontitis
Egypt60 participantsStarted 2025-11-01
Plain-language summary
melatonin loaded in injectible platelet rich fibrin in treatment of periodontitis
Who can participate
Age range20 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- Diagnosed with stage II periodontitis based on AAP/EFP 2018 classification
• Minimum of two non-adjacent periodontal pockets \<5 mm in different quadrants
• Systemically healthy individuals willing to participate and comply with follow-up visits
• Radiographic bone loss (ranged from is 10-20% mostly horizontal
Exclusion Criteria:
History of systemic diseases affecting periodontium (e.g., diabetes, osteoporosis)
• Use of antibiotics, anti-inflammatories, or antioxidant supplements in the past 3 months
• Smoking or tobacco use
• Pregnancy or lactation
• Allergy to melatonin or related compounds
\-